These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 11084551

  • 1. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO, Oz U, Shahabi S, Mahoney MJ, Baumgarten A, Cole LA.
    Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
    [Abstract] [Full Text] [Related]

  • 2. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population.
    Bahado-Singh R, Oz U, Shahabi S, Omrani A, Mahoney M, Cole L.
    Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986
    [Abstract] [Full Text] [Related]

  • 3. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R, Oz U, Rinne K, Hunter D, Cole L, Mahoney MJ, Baumgarten A.
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [Abstract] [Full Text] [Related]

  • 4. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE.
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [Abstract] [Full Text] [Related]

  • 5. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL.
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [Abstract] [Full Text] [Related]

  • 6. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT.
    CMAJ; 1996 Feb 15; 154(4):465-79. PubMed ID: 8630836
    [Abstract] [Full Text] [Related]

  • 7. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
    Bahado-Singh RO, Oz AU, Gomez K, Hunter D, Copel J, Baumgarten A, Mahoney MJ.
    Ultrasound Obstet Gynecol; 2000 Mar 15; 15(3):199-204. PubMed ID: 10846774
    [Abstract] [Full Text] [Related]

  • 8. New triple screen test for Down syndrome: combined urine analytes and serum AFP.
    Bahado-Singh RO, Oz U, Kovanci E, Cermik D, Flores D, Copel J, Mahoney M, Cole L.
    J Matern Fetal Med; 1998 Mar 15; 7(3):111-4. PubMed ID: 9642606
    [Abstract] [Full Text] [Related]

  • 9. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA, Ying J, Beazoglou T, Egan JF.
    Prenat Diagn; 2001 Jan 15; 21(1):46-51. PubMed ID: 11180240
    [Abstract] [Full Text] [Related]

  • 10. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Jan 15; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 11. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
    Cole LA, Shahabi S, Oz UA, Rinne KM, Omrani A, Bahado-Singh RO, Mahoney MJ.
    Prenat Diagn; 1999 Apr 15; 19(4):351-9. PubMed ID: 10327141
    [Abstract] [Full Text] [Related]

  • 12. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA.
    N Engl J Med; 1994 Apr 21; 330(16):1114-8. PubMed ID: 7510852
    [Abstract] [Full Text] [Related]

  • 13. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Sep 21; 110(3):651-7. PubMed ID: 17766613
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA, Peterson CJ, French CA, Saller DN, Arvan DA.
    Obstet Gynecol; 1994 Aug 21; 84(2):298-303. PubMed ID: 7518896
    [Abstract] [Full Text] [Related]

  • 15. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA.
    Prenat Diagn; 1998 Apr 21; 18(4):319-24. PubMed ID: 9602476
    [Abstract] [Full Text] [Related]

  • 16. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
    Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ.
    Clin Chem; 1999 Dec 21; 45(12):2109-19. PubMed ID: 10585342
    [Abstract] [Full Text] [Related]

  • 17. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S, Chandeying V.
    J Med Assoc Thai; 2007 Oct 21; 90(10):1970-6. PubMed ID: 18041410
    [Abstract] [Full Text] [Related]

  • 18. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD, McIntosh SF, Halstead AC.
    Prenat Diagn; 2005 Mar 21; 25(3):234-8. PubMed ID: 15791658
    [Abstract] [Full Text] [Related]

  • 19. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
    Bahado-Singh R, Shahabi S, Karaca M, Mahoney MJ, Cole L, Oz UA.
    Am J Obstet Gynecol; 2002 Apr 21; 186(4):803-8. PubMed ID: 11967511
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.